GovChime
Notice ID: fba2112d7da54dc49033b9adbe509953SolicitationArchived

Marburg virus (MARV) and Sudan virus (SUDV) Vaccines

Archived on September 11, 2025. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
2:00 PM EDT
Posted
July 31, 2025
Notice type
Solicitation
Set-aside
No Set aside used
NAICS
541714: Research and Development in Biotechnology (except Nanobiotechnology)
Agency
Department of Health and Human ServicesOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE

Notice details

Office
BARDA - ASPR / DAAPPO / BARDA DCMA
Place of performance
Washington
Last updated
Nov 10, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
75A50125R00006
Notice ID
fba2112d7da54dc49033b9adbe509953

Description

The 2014 Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Strategy and Implementation Plan identifies Ebola virus and Marburg virus as high-priority threats as determined by the Department of Homeland Security to present a material threat to national security. Strategies to mitigate the threat of Ebola virus and Marburg virus include the development of vaccines suitable for protection against Ebola and Marburg virus disease respectively. BARDA is seeking vaccines that can be safely and effectively used for the U.S. civilian population in individuals with an elevated risk of exposure to Sudan virus (SUDV) and Marburg virus (MARV). This acquisition will allow BARDA to invest Project BioShield funds for the advanced development, US Food and Drug Administration (FDA) licensure, procurement, shipping, and vendor managed inventory (VMI) storage of MARV and SUDV monovalent vaccines.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

Files (3)

  • 75A50125R00006 Amendment 2.pdf

    1.3 MBAdded in Solicitation version 7Posted
    Download
  • 75A50125R00006 QA.pdf

    123 KBAdded in Solicitation version 7Posted
    Download
  • Pre-Solicitation Notice 75A50125R00006.pdf

    187 KBAdded in Presolicitation version 4Posted
    Download

Lifecycle

  1. 5
    Version 5PresolicitationArchived

    Marburg virus (MARV) and Sudan virus (SUDV) Vaccines

    Notice 66553ff7754346dca558f3e8719cb32b on SAM.gov

  2. 2
    Version 2SolicitationArchived

    Type changed from Presolicitation to Solicitation

    Marburg virus (MARV) and Sudan virus (SUDV) Vaccines

    Notice 1245b97261a248c098f549dc050eb35a on SAM.gov

  3. 3
    Version 3SolicitationArchived

    Marburg virus (MARV) and Sudan virus (SUDV) Vaccines

    Notice fb1420f8176f4a6b89f7a21fb7569726 on SAM.gov

  4. 7
    Version 7SolicitationArchivedCurrent

    Marburg virus (MARV) and Sudan virus (SUDV) Vaccines

    Notice fba2112d7da54dc49033b9adbe509953 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75A50125R00006

Archive Date

Sep 11, 2025